MAPT and Alzheimer disease: While altered levels in blood compartments have been more thoroughly studied, t-tau and p-tau are also upregulated in AD lymphocytes, and p-tau overexpression has been characterized in AD platelets and olfactory and buccal epithelia, facilitating their potential as accessible biomarkers [17,32].